Found: 17
Select item for more details and to access through your institution.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 514, doi. 10.1002/cpdd.782
- By:
- Publication type:
- Article
Smoking cessation and associated risk of metabolic syndrome in women.
- Published in:
- Women's Health (17455057), 2012, v. 8, n. 4, p. 367, doi. 10.2217/whe.12.31
- By:
- Publication type:
- Article
The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2017, p. 4124, doi. 10.1210/jc.2017-00957
- By:
- Publication type:
- Article
The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001-2010.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Once‐daily oral small‐molecule glucagon‐like peptide‐1 receptor agonist lotiglipron (PF‐07081532) for type 2 diabetes and obesity: Two randomized, placebo‐controlled, multiple‐ascending‐dose Phase 1 studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3155, doi. 10.1111/dom.15643
- By:
- Publication type:
- Article
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2805, doi. 10.1111/dom.15168
- By:
- Publication type:
- Article
A phase 2a, randomized, double‐blind, placebo‐controlled, three‐arm, parallel‐group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF‐06835919 in patients with non‐alcoholic fatty liver disease and type 2 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 992, doi. 10.1111/dom.14946
- By:
- Publication type:
- Article
A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 805, doi. 10.1111/dom.14928
- By:
- Publication type:
- Article
Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: national health and nutrition examination survey 2001-2008.
- Published in:
- Environmental Health: A Global Access Science Source, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-069X-13-6
- By:
- Publication type:
- Article
Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: National Health and Nutrition Examination Survey 2001-2008.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2314493, doi. 10.1001/jamanetworkopen.2023.14493
- By:
- Publication type:
- Article
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.
- Published in:
- BMC Pregnancy & Childbirth, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2393-13-85
- By:
- Publication type:
- Article
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Energy intake as a short‐term biomarker for weight loss in adults with obesity receiving liraglutide: A randomized trial.
- Published in:
- Obesity Science & Practice, 2021, v. 7, n. 3, p. 281, doi. 10.1002/osp4.486
- By:
- Publication type:
- Article
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 4, p. 449, doi. 10.1002/jcph.2371
- By:
- Publication type:
- Article
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2024, v. 15, n. 3, p. 1054, doi. 10.1002/jcsm.13435
- By:
- Publication type:
- Article